CLINICAL_TRIALS
trial_result
· 2023-11-02
Clinical Trial Update: Efficacy and Safety of Odevixibat in Patients With Alagille Syndrome [Phase 3]
Summary
Phase 3 trial results update on the efficacy and safety of odevixibat in patients with Alagille syndrome.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Albireo | Conditions: Alagille Syndrome | Phase 3 | Status: COMPLETED | Results posted: 2023-11-02